急性心力衰竭:从基于症状的护理过渡到缓解
Gad Cotter1, Beth A Davison1, Douglas L Mann2
1Université Paris Cité, INSERM UMR-S 942 (MASCOT), Paris, France; Heart Initiative, Durham, NC, USA; Momentum Research, Durham, NC, USA.
Journal of cardiac failure
|February 14, 2025
概括
急性心力衰竭 (AHF) 的患者个人资料已经发展,需要更新治疗策略. 研究表明,将抗炎疗法与神经激素抑制剂结合起来,可能会改善AHF患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 老年病的医生 老年病的医生
背景情况:
- 心力衰竭 (HF) 患者的人口统计学已经转向了年长,更肥胖的个体,具有多种并发症.
- 急性心力衰竭 (AHF) 的潜在病理生理学现在涉及年龄,肥胖和伴随性疾病相关的心血管功能障碍,以及神经激素和炎症失调 ("炎症").
- 对AHF的治疗重点已经从立即的症状缓解演变为长期的生活质量和结果的改善.
研究的目的:
- 评估急性心力衰竭 (AHF) 患者特征和病理生理学的不断变化的格局.
- 评估指南导向医疗疗 (GDMT) 支柱的适用性,主要是神经激素阻塞,对AHF.
- 探索抗炎疗法在治疗AHF方面的潜力,特别是在炎症标志物升高的患者中.
主要方法:
- 对HF和AHF患者群体和病理生理学的历史趋势的审查.
- 对最近研究的分析,研究慢性HFGDMT在住院期间和之后扩展到AHF患者.
- 考虑试点研究的结果,如CORTAHF,检查AHF的抗炎干预措施.
主要成果:
- 对于AHF的患者概况已经过渡到更老的,更多的并发症患者.
- 神经激素阻断是慢性HF管理的基石,在AHF早期和积极应用时显示出希望.
- 试验数据表明,抗炎治疗可能为炎症激活的AHF患者提供额外的益处.
结论:
- 目前的AHF管理应纳入GDMT原则,包括神经激素抑制剂的快速启动和定位.
- 需要进一步的研究来研究联合抗炎和神经激素阻塞疗法对AHF的协同效应.
- 探索组合疗法可能会导致AHF患者改善病理生理学逆转和潜在的缓解.
相关概念视频
01:29Acute Respiratory Failure-V
114
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
114
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
371
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
371
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:22Heart Failure Drugs: Diuretics
334
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
334
01:22Heart Failure Drugs: β-Blockers
308
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
308
01:19Restorative Care
1.9K
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
1.9K